Repeated Courses of Oral Ibuprofen in Premature Infants with Patent Ductus Arteriosus: Efficacy and Safety


Olgun H., CEVİZ N., KARTAL I., Caner I., KARACAN M., TAŞTEKİN A., ...More

PEDIATRICS AND NEONATOLOGY, vol.58, no.1, pp.29-35, 2017 (SCI-Expanded, Scopus)

  • Publication Type: Article / Article
  • Volume: 58 Issue: 1
  • Publication Date: 2017
  • Doi Number: 10.1016/j.pedneo.2015.04.017
  • Journal Name: PEDIATRICS AND NEONATOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.29-35
  • Keywords: ibuprofen, multiple course, patent ductus arteriosus, preterm infants, BIRTH-WEIGHT INFANTS, BILIRUBIN-ALBUMIN BINDING, PRETERM INFANTS, MULTIPLE COURSES, CONTROLLED-TRIAL, RISK-FACTORS, INDOMETHACIN, CLOSURE, PROPHYLAXIS
  • Ataturk University Affiliated: Yes

Abstract

BACKGROUND: There are limited data about the results of repeated oral ibuprofen (OIBU) treatment. This study aimed to describe patent ductus arteriosus (PDA) closure rates and adverse events after repeated courses of OIBU in premature infants with PDA.